Blueprint Medicines Details
Blueprint Medicines develops kinase inhibitors for genomically defined cancer subsets of precision therapies, designed to allow patients to live longer and healthier lives.
Employees:
500 - 999
HQ:
617-374-7580
Location:
Cambridge, MA, US
Revenue:
100 - 500 Million
Oncology drug discovery
Oncology
Genomically defined diseases
Rare diseases
Transformative drugs
Robust drug pipeline
Systemic mastocytosis
Hepatocellular carcinoma
Orphan drugs
Small molecules
Kinase inhibitor
Personalized medicine
Novel cancer therapies
B2B
Biotech
SaaS
Commercial Physical Research
Biotechnology
Biotech Pharmaceuticals